+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relation Of The Time In Therapeutic Range (Ttr) Of Warfarin To Bleeding Incidences In Patients With Atrial Fibrillation



Relation Of The Time In Therapeutic Range (Ttr) Of Warfarin To Bleeding Incidences In Patients With Atrial Fibrillation



Value in Health 17(7): A478




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058727702

Download citation: RISBibTeXText

PMID: 27201388

DOI: 10.1016/j.jval.2014.08.1375


Related references

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation. Oncotarget 7(34): 54194-54199, 2016

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin. Stroke 47(6): 1665-1668, 2016

Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin. Postgraduate Medical Journal 94(1110): 207-211, 2018

Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. Journal of Cardiovascular Pharmacology 58(1): 87-90, 2011

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. American Heart Journal 170(1): 141-8 148.E1, 2015

Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA 2 DS 2 -VASc and Time in Therapeutic Range. Canadian Journal of Cardiology 32(10): 1247.E15-1247.E21, 2016

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. Current Medical Research and Opinion 32(1): 87-94, 2016

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction. Journal of the American Heart Association 6(3):, 2017

Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors-. Circulation Journal 75(9): 2087-2094, 2011

Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries. Thrombosis and Haemostasis 117(12): 2291-2299, 2017

Evaluation of Time in Therapeutic Range (TTR) in Patients with Non-Valvular Atrial Fibrillation Receiving Treatment with Warfarin in Tehran, Iran: A Cross-Sectional Study. Journal of Clinical and Diagnostic Research 10(9): Fc04-Fc06, 2016

Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry. Cardiology Journal 22(5): 567-575, 2015

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis. Plos one 12(11): E0188482, 2017

NOAC or Warfarin for Atrial Fibrillation: Does Time in Therapeutic Range Matter?. Recent Advances in Cardiovascular Drug Discovery 10(1): 60-64, 2015

Noac or warfarin for Atrial Fibrillation: does time in therapeutic range matter?. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) 10(1): 60-64, 2016